Annual report for Kilitch Drugs(I) Ltd. for FY-2023
30-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2023, Pursuant To Regulation 23(9) Of Tile SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions of the Company for the half-year ended 31st March, 2023.29-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 29Th May, 2023
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we hereby would like to inform you that Board of Directors of the Company, at its meeting held today i.e. 29th May, 2023 have considered and approved the following; 1. Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023. The copy of Audited Financial Results (Standalone and Consolidated) as adopted and approved by the Board of Directors and Auditor''s report thereon are attached herewith for your ready reference. 2. Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified (i.e., unqualified) opinion on the Financial Statements (Standalone and Consolidated) for the year ended on 31st March, 2023.29-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 29Th May, 2023
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we hereby would like to inform you that Board of Directors of the Company, at its meeting held today i.e. 29th May, 2023 have considered and approved the following; 1. Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023. The copy of Audited Financial Results (Standalone and Consolidated) as adopted and approved by the Board of Directors and Auditor''s report thereon are attached herewith for your ready reference. 2. Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified (i.e., unqualified) opinion on the Financial Statements (Standalone and Consolidated) for the year ended on 31st March, 2023.29-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Financial Results For The Quarter And Year Ended 31St March, 2023
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we hereby would like to inform you that Board of Directors of the Company, at its meeting held today i.e. 29th May, 2023 have considered and approved the following; 1. Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023. The copy of Audited Financial Results (Standalone and Consolidated) as adopted and approved by the Board of Directors and Auditor''s report thereon are attached herewith for your ready reference. 2. Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified (i.e., unqualified) opinion on the Financial Statements (Standalone and Consolidated) for the year ended on 31st March, 2023.29-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Corrigendum To The Intimation Of Conference Call With Investors And Analysts
This has reference to our earlier letter dated 29th May, 2023 regarding Intimation of Conference Call with Investors and Analysts. Post submission of said intimation an inadvertent error was noticed that the hyperlink to register / join the meeting is disabled. The invite with the hyperlink to register / join the meeting is enclosed herewith.29-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will be hosting an investor and analyst conference call on Friday, 2nd June, 2023 at 12:00 PM IST to discuss the performance for the quarter and financial year ended 31st March, 2023 as per the invite attached.29-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report for the financial year ended 31st March, 2023 issued by practicing company secretary, Deep Shukla & Associates dated 10th May, 202323-05-2023
KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for Considering The Financial Results For The Quarter And Year Ended 31St March, 2023
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the meeting of the Board of Directors of the Company will be held on Monday, 29th May, 2023 inter-alia to consider and approve the audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 202317-05-2023